Get started
Author

Annukka A.R. Antar

Observed names: A Antar, Annuka Antar, Annukka A.R. Antar, Annukka A R Antar, Annukka A. R. Antar, Annukka AR Antar, Annukka Antar, Antar, Annukka A. R.
ORCID: 0000-0002-6775-1103
Observed ORCID: 0000-0002-6775-1103
OpenAlex ID: A5079932972
A quantitative approach for measuring the reservoir of latent HIV-1 proviruses
2019 · Katherine M. Bruner, Zheng Wang, et al. · Nature · 718
PDF
A Plasmid-Based Reverse Genetics System for Animal Double-Stranded RNA Viruses
2007 · Takeshi Kobayashi, Annukka A.R. Antar, et al. · Cell Host & Microbe · 263
PDF
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019
2020 · Dima Dandachi, Grant Geiger, et al. · Clinical Infectious Diseases · 214
PDF
Junctional Adhesion Molecule-A Is Required for Hematogenous Dissemination of Reovirus
2009 · Annukka A.R. Antar, Jennifer L. Konopka, et al. · Cell Host & Microbe · 121
PDF
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections
2019 · Alexandra M. Bender, Francesco R. Simonetti, et al. · Cell Host & Microbe · 99
PDF
Durable SARS-CoV-2 B cell immunity after mild or severe disease
2021 · Clinton O. Ogega, Nicole E. Skinner, et al. · Journal of Clinical Investigation · 92
PDF
Longitudinal study reveals HIV-1–infected CD4+ T cell dynamics during long-term antiretroviral therapy
2020 · Annukka A.R. Antar, Katharine M. Jenike, et al. · Journal of Clinical Investigation · 83
PDF
Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
2021 · Ahmad Al-Abdouh, Anas Bizanti, et al. · Contemporary Clinical Trials · 79
The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study
2021 · Paul W Blair, Diane M Brown, et al. · Open Forum Infectious Diseases · 71
Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6–12 Months Postinfection
2024 · Zoe O Demko, Tong Yu, et al. · Open Forum Infectious Diseases · 68
PDF
Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19
2021 · Shannon Wongvibulsin, Brian T. Garibaldi, et al. · Annals of Internal Medicine · 54
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection
2023 · Annukka A. R. Antar, Tong Yu, et al. · Frontiers in Immunology · 50
PDF
The role of CD32 during HIV-1 infection
2018 · Lynn N. Bertagnolli, Jennifer A. White, et al. · Nature · 49
Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae
2018 · Patricia J Simner, Annukka A R Antar, et al. · Journal of Antimicrobial Chemotherapy · 44
PDF
Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients
2022 · Santosh Dhakal, Tong Yu, et al. · Open Forum Infectious Diseases · 43
Pregnancy alters interleukin-1 beta expression and antiviral antibody responses during severe acute respiratory syndrome coronavirus 2 infection
2021 · Morgan L. Sherer, Jun Lei, et al. · American Journal of Obstetrics and Gynecology · 32
PDF
Dysregulated immunity in SARS-CoV-2 infected pregnant women
2020 · Morgan L. Sherer, Jun Lei, et al. · medRxiv · 28
PDF
Self-Collected Oral Fluid Saliva Is Insensitive Compared With Nasal-Oropharyngeal Swabs in the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Outpatients
2020 · Yukari C Manabe, Carolyn Reuland, et al. · Open Forum Infectious Diseases · 22
PDF
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
2022 · Nora Pisanic, Annukka A.R. Antar, et al. · Journal of Immunological Methods · 21
High-value Laboratory Testing for Hospitalized COVID-19 Patients: A Review
2021 · Daniela Cihakova, Michael B Streiff, et al. · Future Virology · 21
Translating insights into therapies for Long Covid
2024 · Annukka A. R. Antar, Andrea L. Cox · Science Translational Medicine · 20
Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution
2024 · Nora Pisanic, Annukka A R Antar, et al. · The Journal of Infectious Diseases · 20
PDF
Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients
2021 · Annukka A R Antar, Tong Yu, et al. · Open Forum Infectious Diseases · 16
PDF
Long COVID in people living with HIV
2023 · Michael J. Peluso, Annukka A.R. Antar · Current Opinion in HIV and AIDS · 15
PDF
Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study
2024 · Carly Herbert, Annukka A R Antar, et al. · Clinical Infectious Diseases · 13
PDF
Works count: 61
Citation count: 2,354
H-index: 20
I10-index: 26
Year
Topic
Type